The Efficiency of Pain Control Using a Thigh Pad Under the Elastic Stocking in Patients Following Venous Stripping: Results of a Case-Control Study

Benigni, J. P.; Allaert, François-André; Desoutter, P; Cohen‐Solal, G.; Stalnikiewicz, X.

doi:10.1177/1531003511431737

Cited by 15 publications

(20 citation statements)

References 3 publications

(4 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Benigni et al. 41 compared pain intensity on Days 1 and 7 and global mean pain during the week following stripping of the GSV in patients for whom either a pad had been added at thigh level under an MCS or patients with an MCS only. Pain was significantly reduced in the pad plus MCS group (p < 0.0001).…”

Section: Recommendationsmentioning

confidence: 99%

“…Three studies have shown that local high interface pressure, along the GSV at the thigh, can reduce pain. 40 – 42 …”

Section: Recommendationsmentioning

confidence: 99%

“… 31 The more recent studies either did not follow the patients for a long enough period of time or had failed to demonstrate benefits from ongoing MCS use after the initial postoperative period. 37 – 42 , 45 However, not all patients return to asymptomatic clinical class C0 after venous interventions, even if they have improved clinically, and so may still require MCS treatment. These patients include those who are post-thrombotic after superficial insufficiency treatment, or patients with healed or active VLU, after varicose vein treatment.…”

Section: Recommendationsmentioning

confidence: 99%

See 2 more Smart Citations

Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement

et al. 2017

View full text Add to dashboard Cite

ObjectiveMedical compression stockings are a standard, non-invasive treatment option for all venous and lymphatic diseases. The aim of this consensus document is to provide up-to-date recommendations and evidence grading on the indications for treatment, based on evidence accumulated during the past decade, under the auspices of the International Compression Club.MethodsA systematic literature review was conducted and, using PRISMA guidelines, 51 relevant publications were selected for an evidence-based analysis of an initial 2407 unrefined results. Key search terms included: ‘acute', CEAP', ‘chronic', ‘compression stockings', ‘compression therapy', ‘lymph', ‘lymphatic disease', ‘vein' and ‘venous disease'. Evidence extracted from the publications was graded initially by the panel members individually and then refined at the consensus meeting.ResultsBased on the current evidence, 25 recommendations for chronic and acute venous disorders were made. Of these, 24 recommendations were graded as: Grade 1A (n = 4), 1B (n = 13), 1C (n = 2), 2B (n = 4) and 2C (n = 1). The panel members found moderately robust evidence for medical compression stockings in patients with venous symptoms and prevention and treatment of venous oedema. Robust evidence was found for prevention and treatment of venous leg ulcers. Recommendations for stocking-use after great saphenous vein interventions were limited to the first post-interventional week. No randomised clinical trials are available that document a prophylactic effect of medical compression stockings on the progression of chronic venous disease (CVD). In acute deep vein thrombosis, immediate compression is recommended to reduce pain and swelling. Despite conflicting results from a recent study to prevent post-thrombotic syndrome, medical compression stockings are still recommended. In thromboprophylaxis, the role of stockings in addition to anticoagulation is limited. For the maintenance phase of lymphoedema management, compression stockings are the most important intervention.ConclusionThe beneficial value of applying compression stockings in the treatment of venous and lymphatic disease is supported by this document, with 19/25 recommendations rated as Grade 1 evidence. For recommendations rated with Grade 2 level of evidence, further studies are needed.

show abstract

Section: Recommendationsmentioning

confidence: 99%

“…Three studies have shown that local high interface pressure, along the GSV at the thigh, can reduce pain. 40 – 42 …”

Section: Recommendationsmentioning

confidence: 99%

Section: Recommendationsmentioning

confidence: 99%

See 1 more Smart Citation

Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement

et al. 2017

View full text Add to dashboard Cite

show abstract

“…[3,35] In contrast to a comparison of limited daily values, the AUC method can provide an overall view of the evolution of individual patients' symptoms over a given period. A similar approach is used in the research of pain, [36] where sequential measurement is subject to similar fluctuations. Our results show that, in terms of the reduction in the HFS, the evolution of the HFS over the period of the study was significantly better in the BRN-01 group than in the placebo group.…”

Section: Discussionmentioning

confidence: 99%

Efficacy of a Non-Hormonal Treatment, BRN-01, on Menopausal Hot Flashes

et al. 2012

View full text Add to dashboard Cite

Background: Homeopathic medicines have a place among the non-hormonal therapies for the treatment of hot flashes during the menopause. Objective: The objective of this study was to evaluate the efficacy of the nonhormonal treatment BRN-01 in reducing hot flashes in menopausal women. Study Design: This was a multicenter, randomized, double-blind, placebocontrolled study carried out between June 2010 and July 2011. Setting: The study was conducted in 35 active centers in France (gynecologists in private practice). Patients: One hundred and eight menopausal women, ‡50 years of age, were enrolled in the study. The eligibility criteria included menopause for <24 months and ‡5 hot flashes per day with a significant negative effect on the women's professional and/or personal life. Intervention: Treatment was either BRN-01 tablets, a registered homeopathic medicine containing Actaea racemosa (4 centesimal dilutions [4CH]), Arnica montana (4CH), Glonoinum (4CH), Lachesis mutus (5CH), and Sanguinaria canadensis (4CH), or identical placebo tablets, prepared by Laboratoires Boiron according to European Pharmacopoeia standards. Oral treatment (2 to 4 tablets per day) was started on day 3 after study enrollment and was continued for 12 weeks. Main Outcome Measure: The main outcome measure was the hot flash score (HFS) compared before, during, and after treatment. Secondary outcome criteria were the quality of life (QoL) [measured using the Hot Flash Related Daily Interference Scale (HFRDIS)], severity of symptoms (measured using the Menopause Rating Scale), evolution of the mean dosage, and compliance. All adverse events (AEs) were recorded. Results: One hundred and one women were included in the final analysis (intent-to-treat population: BRN-01, n = 50; placebo, n = 51). The global HFS over the 12 weeks, assessed as the area under the curve (AUC) adjusted for

show abstract

“…It is a standard treatment for a range of indications from prevention to postoperative care (6,12,13). By contrast, "eccentric" compression involves the additional use of pressure devices when attempting a specific increase in local pressure, such as along the course of an extracted or sclerosed vein (1,8,9).…”

Section: Schlüsselwörter Kompressionmentioning

confidence: 99%

Eccentric compression of large varicose veins after foam sclerotherapy using a novel silicone gel pad

Ragg¹

2014

Phlebologie

View full text Add to dashboard Cite

ZusammenfassungZiel: Wir evaluierten eine neuartige exzentrische Kompression, die ultraschalltransparentes Silikon-Gel zwischen selbstklebenden Fo-lien als individuelles Druckpolster verwendet.Methodik: Es wurden 120 Patienten mit 148 oberflächlichen Varizen (Ø 5,1–13,7 mm; MW: 7,6) nach Schaumverödung einbezogen: A) segmental randomisiert mit fokaler Kompression durch Silikon-Gel-Polster (Venartis® SGP) für 14 Tage plus Kompressionsstrumpf KKl. 2 (KS) tagsüber für 28 Tage, oder B) nur KS. Das SGP-System besteht aus einer selbstklebenden Basisfolie, auf die Silikon dem Venenverlauf folgend aufgetragen wird. Eine zweite Folie bedeckt Gel und Basisfolie. Den Patienten war Duschen erlaubt. Ermittelt wurden Querschnittsreduktion (QR, Ultra-schallscans) sowie klinische Parameter nach 2, 4 und 8 Wochen.Ergebnisse: Segmente mit SGP zeigten gegenüber KS eine höhere QR, im Mittel 52,5 vs. 23,1 % (2 Wo), 48,4 vs. 28,9 % (4 Wo) und 66,7 vs. 39,2 % (8 Wo). Entzündungsreaktionen waren unter SGP mit 12,4 vs. 39,9 % signifikant seltener, ebenso Verfärbungen mit 10,8 vs. 35,1 %. Minithrombektomien (8,1 vs. 29,7 %) und orale Analgetika (6,8 vs. 19,6 %) wurden seltener benötigt. Unerwünschte Wirkungen: Diskrete Hautirritationen (10,1 %).Schlussfolgerung: Indikationsspezifische Silikonhärten, Dosierungen, Tragezeiten und die Höhe externer Drücke bedürfen weiterer Untersuchungen, wobei die Ultraschalltransparenz neue Wege eröffnet.

show abstract

The Efficiency of Pain Control Using a Thigh Pad Under the Elastic Stocking in Patients Following Venous Stripping: Results of a Case-Control Study

Abstract: The results of this case-control study show that the addition of a pad at thigh level under the elastic compression stocking significantly reduces pain experienced by patients during the week after stripping surgery by 49%.

Cited by 15 publications

References 3 publications

Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement

Indications for medical compression stockings in venous and lymphatic disorders: An evidence-based consensus statement

Efficacy of a Non-Hormonal Treatment, BRN-01, on Menopausal Hot Flashes

Eccentric compression of large varicose veins after foam sclerotherapy using a novel silicone gel pad

Contact Info

Product

Resources

About